Aleman André, Sommer Iris E, Kahn René S
BCN Neuroimaging Center, University Medical Center Groningen, University of Groningen, the Netherlands.
J Clin Psychiatry. 2007 Mar;68(3):416-21. doi: 10.4088/jcp.v68n0310.
Slow repetitive transcranial magnetic stimulation (rTMS), at a frequency of 1 Hz, has been proposed as a treatment for auditory hallucinations. Several studies have now been reported regarding the efficacy of TMS treatment, but results were inconsistent. Therefore, meta-analytic integration of the published trials is needed to evaluate the prospects of this new treatment.
A literature search was conducted using PubMed and Web of Science for the years 1966 until February 2006. We used the search terms transcranial magnetic stimulation, TMS, rTMS, and hallucination*.
From 15 treatment studies published since 1999, ten were sham-controlled trials and provided sufficient valid information to be included. All studies targeted the left tem-poroparietal cortex using 1 Hz rTMS.
Standardized mean gain effect sizes of real rTMS versus sham rTMS were computed based on pretreatment-posttreatment comparisons (computed from mean and SD values or t or F statistics).
After calculation of treatment gain on hallucination ratings using standardized mean differences (sham vs. active rTMS), a mean weighted effect size was computed in the random effects model. We observed a significant mean weighted effect size for rTMS versus sham across the 10 studies, involving 212 patients, d = 0.76 (95% CI = 0.36 to 1.17). When only studies were included that used continuous stimulation (9 studies), the mean effect size increased to d = 0.88 and heterogeneity disappeared. There was no significant effect of rTMS on a composite index of general psychotic symptoms.
The results of this meta-analysis provide evidence for the efficacy of rTMS as an intervention that selectively alters neurobiologic factors underlying auditory hallucinations.
已提出以1赫兹的频率进行慢重复经颅磁刺激(rTMS)作为治疗幻听的一种方法。目前已有多项关于经颅磁刺激治疗效果的研究报道,但结果并不一致。因此,需要对已发表的试验进行荟萃分析,以评估这种新疗法的前景。
利用PubMed和科学网对1966年至2006年2月期间的文献进行检索。我们使用的检索词为经颅磁刺激、TMS、rTMS和幻觉*。
从1999年以来发表的15项治疗研究中,有10项为假对照试验,并提供了足够的有效信息以纳入分析。所有研究均使用1赫兹rTMS靶向左侧颞顶叶皮质。
基于治疗前-治疗后的比较(根据均值和标准差或t或F统计量计算),计算真实rTMS与假rTMS的标准化平均增益效应量。
在使用标准化平均差异(假刺激与活性rTMS)计算幻觉评分的治疗增益后,在随机效应模型中计算平均加权效应量。我们在涉及212名患者的10项研究中观察到rTMS与假刺激相比有显著的平均加权效应量,d = 0.76(95%CI = 0.36至1.17)。当仅纳入使用连续刺激的研究时(9项研究),平均效应量增加到d = 0.88,异质性消失。rTMS对一般精神症状综合指数没有显著影响。
这项荟萃分析的结果为rTMS作为一种选择性改变幻听潜在神经生物学因素的干预措施的疗效提供了证据。